Search research articles
Contact Us
Filters
Showing results (41-50 of 218) with videos related to
Page
of 22
Sort By:
British Journal of Cancer
|
November 1, 1990
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients
P Lissoni, G Tancini, F Rovelli, et al.
Medical and Pediatric Oncology
|
January 1, 1977
Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas
S Monfardini, G Tancini, M DeLena, et al.
Tumori
|
February 28, 1993
A weekly schedule of epirubicin in pretreated advanced breast cancer
S Barni, C Archili, P Lissoni, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 1, 1995
Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II study
P Lissoni, S Barni, F Brivio, et al.
The International Journal of Biological Markers
|
April 1, 1991
Blood levels of IGF-I in non-small cell lung cancer: relation to clinical data
E Tisi, P Lissoni, F Rovelli, et al.
Cancer Clinical Trials
|
January 1, 1979
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer
G Tancini, E Bajetta, S Marchini, et al.
Tumori
|
February 28, 1990
A study of the pineal hormone melatonin as a second line therapy in metastatic colorectal cancer resistant to fluorouracil plus folates
S Barni, P Lissoni, F Paolorossi, et al.
Cancer
|
February 1, 1994
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
P Lissoni, S Barni, A Ardizzoia, et al.
European Journal of Cancer
|
April 1, 1980
Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma
R Molinari, F Mattavelli, G Cantù, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 1, 1994
Weekly epirubicin plus low-dose interleukin-2 subcutaneous therapy in breast cancer: preliminary immunobiological results
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 22
Search research articles
Search
Showing results (41-50 of 218) with videos related to
Sort By:
Page
of 22
British Journal of Cancer
|
November 1, 1990
Serum interleukin-2 levels in relation to the neuroendocrine status in cancer patients
P Lissoni, G Tancini, F Rovelli, et al.
Medical and Pediatric Oncology
|
January 1, 1977
Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas
S Monfardini, G Tancini, M DeLena, et al.
Tumori
|
February 28, 1993
A weekly schedule of epirubicin in pretreated advanced breast cancer
S Barni, C Archili, P Lissoni, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 1, 1995
Treatment of cancer-related thrombocytopenia by low-dose subcutaneous interleukin-2 plus the pineal hormone melatonin: a biological phase II study
P Lissoni, S Barni, F Brivio, et al.
The International Journal of Biological Markers
|
April 1, 1991
Blood levels of IGF-I in non-small cell lung cancer: relation to clinical data
E Tisi, P Lissoni, F Rovelli, et al.
Cancer Clinical Trials
|
January 1, 1979
Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer
G Tancini, E Bajetta, S Marchini, et al.
Tumori
|
February 28, 1990
A study of the pineal hormone melatonin as a second line therapy in metastatic colorectal cancer resistant to fluorouracil plus folates
S Barni, P Lissoni, F Paolorossi, et al.
Cancer
|
February 1, 1994
A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms
P Lissoni, S Barni, A Ardizzoia, et al.
European Journal of Cancer
|
April 1, 1980
Results of a low-dose combination chemotherapy with vincristine, bleomycin and methotrexate (V-B-M) based on cell kinetics in the palliative treatment of head and neck squamous cell carcinoma
R Molinari, F Mattavelli, G Cantù, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 1, 1994
Weekly epirubicin plus low-dose interleukin-2 subcutaneous therapy in breast cancer: preliminary immunobiological results
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 22